Gene expression differences between matched pairs of ovarian cancer patient tumors and patient-derived xenografts-Reference-Cited by-同舟云学术

Gene expression differences between matched pairs of ovarian cancer patient tumors and patient-derived xenografts

Published:2019-04-19 Issue:1 Volume:9 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Liu Yuanhang,Chanana Pritha,Davila Jaime I.^ORCID,Hou Xiaonan,Zanfagnin Valentina,McGehee Cordelia D.,Goode Ellen L.,Polley Eric C.,Haluska Paul,Weroha S. John,Wang Chen^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/s41598-019-42680-2.pdf

Reference43 articles.

1. Kung, A. L. Practices and pitfalls of mouse cancer models in drug discovery. Adv Cancer Res 96, 191–212, https://doi.org/10.1016/S0065-230X(06)96007-2 (2007).

2. Johnson, J. I. et al. Relationships between drug activity in NCI preclinical in vitro and in vivo models and early clinical trials. Br J Cancer 84, 1424–1431, https://doi.org/10.1054/bjoc.2001.1796 (2001).

3. Domcke, S., Sinha, R., Levine, D. A., Sander, C. & Schultz, N. Evaluating cell lines as tumour models by comparison of genomic profiles. Nat Commun 4, 2126, https://doi.org/10.1038/ncomms3126 (2013).

4. Daniel, V. C. et al. A primary xenograft model of small-cell lung cancer reveals irreversible changes in gene expression imposed by culture in vitro. Cancer Res 69, 3364–3373, https://doi.org/10.1158/0008-5472.CAN-08-4210 (2009).

5. Hidalgo, M. et al. Patient-derived xenograft models: an emerging platform for translational cancer research. Cancer Discov 4, 998–1013, https://doi.org/10.1158/2159-8290.CD-14-0001 (2014).

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Reversion of pathogenic BRCA1 L1780P mutation confers resistance to PARP and ATM inhibitor in breast cancer;iScience;2024-08

2. Lestaurtinib’s antineoplastic activity converges on JAK/STAT signaling to inhibit advanced forms of therapy resistant ovarian cancer;2024-06-09

3. Recent advances in patient‐derived tumor organoids for reconstructing TME of head and neck cancer;Journal of Oral Pathology & Medicine;2024-04

4. Consistency between Primary Uterine Corpus Malignancies and Their Corresponding Patient-Derived Xenograft Models;International Journal of Molecular Sciences;2024-01-25

5. Unlocking Translational Potential: Conditionally Reprogrammed Cells in Advancing Breast Cancer Research;Cells;2023-09-30